로딩 중…
지수 로딩 중…
Vuno Inc.
338220· KOSDAQ· Health Care· Health Care Equipment & Services
₩8,450-6.73%
2026-06-19
Price Chart
Vuno Inc.-57.96%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 118.32B KRW |
| Revenue | 33.36B KRW |
| Net Income | -6.48B KRW |
| Total Assets | 54.73B KRW |
| Net Assets | 41.12B KRW |
| Employees | 160 |
| Value | |
| P/B | 2.88x |
| P/S | 3.55x |
| FCF Yield | -4.52% |
| Profitability | |
| ROE | -15.76% |
| ROA | -11.84% |
| Op. Margin | -16.83% |
| Revenue Growth | -19.74% |
| Financial Health | |
| Debt Ratio | 133.11% |
| Total Debt | 6.26B KRW |
| FCF | -5.35B KRW |
| Cash | 5.08B KRW |
| Current Ratio | 3.55x |
| Performance | |
| 1Y Return | -57.96% |
| 1M Return | -15.16% |
| From 52W High | -70.19% |
| 1Y MDD | -72.36% |
| Trading | |
| Volume | 85,836 shares |
| Foreign Own. | 3.21% |
| Per Share | |
| EPS | -463 KRW |
| BPS | 2,937 KRW |
Company Info
Vuno, an artificial intelligence medical enterprise founded in 2014, initiated its global business after launching South Korea's first AI medical device in 2018 and listing on KOSDAQ in 2021. The company uses deep learning to analyze medical data, offering diagnostic and predictive products for cardiac arrest risk, lesion detection, X-ray findings, and arrhythmia analysis. By developing its own AI engine, Vuno has reduced dependence on IT companies and is accelerating global market expansion, including securing FDA breakthrough device designation. It is headquartered in Seocho-gu, Seoul.